FISCHER MEDICAL VENTURES LIMITED

BSE: FISCHER524743ISIN INE771F01041

Healthcare
Medical Equipment & Supplies
BSE 1000

Share price

₹25.29+0.67 (+2.72%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

Splits and bonuses

12 Sep 2025 · Split 10:1 (₹10 → ₹1)

52W high: ₹109.20
52W low: ₹21.94
Off 52W high: -76.84%
1M return: -23.06%
3M return: -32.81%
6M return: -33.95%
1Y return: -73.00%
20D avg volume: 1,29,541
50 DMA: ₹31.90
200 DMA: ₹36.31

Key ratios Consolidated

Market cap: ₹1,655 Cr
Current price: ₹25.29
52W high / low: ₹109.20 / ₹21.94
Face value: ₹1.00
P/E: 59.29
P/B: 4.31
EPS (TTM): ₹0.43
Book value / share: ₹5.87
ROE: —
ROCE: 12.70%
Operating margin: —
Net margin: —
Debt / equity: 0.19
Net debt: ₹60.47 Cr
Interest cover: 8.99
Dividend yield: 0.20%
Dividend / share (TTM): ₹0.05
Payout: 11.63%
Cash conversion cycle: 235.2 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	81.92	97.73	101.10	86.31	23.45	49.17	11.75	39.66	10.12	20.79
	1.48	1.28	1.09	2.48	7.47	0.15	0.38	0.22	0.74	0.47
	83.40	99.01	102.18	88.79	30.91	49.32	12.13	39.88	10.86	21.26
	75.57	101.26	80.94	71.48	20.62	47.41	11.88	39.50	10.70	18.51
	43.98	62.09	0.00	0.15	7.58	0.00	—	—	—	15.74
	22.10	6.90	57.81	11.20	0.00	34.72	2.18	40.86	17.52	0.08
	4.52	4.02	4.17	3.75	3.16	0.94	0.75	0.51	0.39	0.34
	3.54	3.61	0.64	0.92	0.67	0.23	0.07	0.05	0.12	0.05
	1.36	0.93	0.77	0.51	0.77	0.51	0.56	0.29	0.28	0.18
	7.93	24.24	26.47	53.62	3.48	6.42	2.97	2.53	1.29	1.48
	7.83	-2.25	21.25	17.30	10.29	1.92	0.25	0.38	0.16	2.75
	0.00	0.00	0.00	0.00	0.00	-0.10	0.00	-0.17	0.00	0.00
	7.83	-2.25	21.25	17.30	10.29	1.81	0.25	0.21	0.16	2.75
	4.04	4.86	1.95	3.37	5.17	0.50	0.42	0.08	0.19	0.17
	3.79	-7.12	19.23	13.90	5.01	1.31	-0.29	0.29	-0.12	2.58
	0.06	-0.11	0.30	2.15	0.77	0.09	-0.05	0.05	-0.02	0.65
Key metrics
	12.73	2.29	22.66	18.73	11.73	2.55	0.88	0.55	0.56	2.98
	15.50%	2.30%	22.40%	21.70%	50.00%	5.20%	7.50%	1.40%	5.50%	14.30%
	4.60%	-7.30%	19.00%	16.10%	21.40%	2.70%	-2.50%	0.70%	-1.20%	12.40%
	—	0.30%	—	4.70%	—	0.50%	—	—	—	—
	249.30%	98.80%	760.40%	117.60%	131.70%	136.50%	—	—	—	—
	-24.40%	-643.50%	6,731.00%	4,693.10%	4,275.00%	-49.20%	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	367.06	308.58	110.70	20.98
	6.33	12.31	1.49	0.50
	373.38	320.89	112.19	21.48
	329.25	274.31	109.48	19.37
	106.22	62.24	0.00	15.74
	98.01	83.49	95.28	0.08
	16.46	15.09	2.58	0.38
	8.71	5.83	0.47	0.07
	3.57	2.98	1.63	0.18
	112.26	107.82	13.21	2.29
	44.13	46.58	2.71	2.11
	0.00	0.00	-0.49	0.00
	44.13	46.58	2.22	2.11
	14.22	15.34	1.01	0.27
	29.80	31.02	1.21	1.84
	2.40	0.48	0.22	1.67
Key metrics
	56.41	55.39	4.32	2.36
	15.37%	17.90%	3.90%	11.20%
	8.12%	10.10%	1.10%	8.80%
	—	12.70%	0.70%	—
	195.94%	178.80%	427.60%	—
	371.52%	2,463.60%	-34.20%	—
	—	-102.58	-92.24	—
	—	-3.26	-71.28	—
	—	0.19	0.18	—
	—	60.47	-43.86	—
	—	235.2	212.9	—
Balance sheet
	—	671.01	457.37	—
	—	417.59	365.29	—
	—	11.89	104.26	—
	—	288.80	76.07	—
	—	12.66	9.16	—
	—	84.49	4.74	—
	—	12.48	14.43	—
	—	102.60	20.65	—
	—	258.03	81.57	—
	—	72.36	60.40	—
	—	72.10	40.67	—
	—	0.26	19.73	—
	—	385.14	337.87	—
Cash flow
	—	-101.27	-86.25	—
	—	-5.22	-125.36	—
	—	14.11	314.92	—
	—	1.31	5.99	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	0.72	4.11	1.31	7.43	4.54	5.22	—	—	—	11.34	—	0.19
	0.89	0.43	0.86	1.44	0.80	0.65	0.87	0.82	1.12	0.72	0.01	0.01
	1.61	4.54	2.17	8.86	5.35	5.87	0.87	0.82	1.12	12.06	0.01	0.20
	4.84	14.71	3.67	7.48	5.56	7.00	0.25	0.36	0.11	11.44	0.15	0.04
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	10.72	—	—
	0.76	2.77	1.37	4.63	3.19	4.55	—	0.07	—	—	—	—
	0.56	0.52	0.62	0.45	0.42	0.05	0.03	0.04	0.03	0.01	0.03	0.01
	1.47	1.27	0.96	1.12	1.31	0.10	—	—	—	—	—	—
	0.77	0.43	0.08	0.08	0.08	0.12	0.03	0.00	0.00	0.00	0.00	—
	1.36	9.67	1.05	1.19	0.57	2.18	0.19	0.31	0.09	0.70	0.12	0.04
	-3.23	-10.17	-1.50	1.38	-0.22	-1.13	0.62	0.46	1.01	0.63	-0.13	0.16
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	-3.23	-10.17	-1.50	1.38	-0.22	-1.13	0.62	0.46	1.01	0.63	-0.13	0.16
	0.27	-1.19	0.17	0.54	0.39	-0.24	0.42	0.05	0.17	0.03	—	0.01
	-3.50	-8.98	-1.67	0.84	-0.61	-0.89	0.20	0.51	0.84	0.60	-0.13	0.14
	-0.05	-0.14	-0.03	0.13	-0.09	-0.06	0.04	0.10	0.16	0.15	-0.76	1.05
Key metrics
	-0.99	-8.47	-0.46	2.58	1.17	-0.91	0.65	0.46	1.01	0.63	-0.13	0.16
	-137.50%	-206.10%	-35.10%	34.70%	25.80%	-17.40%	74.70%	56.10%	90.20%	5.60%	-1,300.00%	84.20%
	-486.10%	-218.50%	-127.50%	11.30%	-13.40%	-17.00%	23.00%	62.20%	75.00%	5.30%	-1,300.00%	73.70%
	—	-2.40%	—	0.70%	—	-0.30%	—	—	—	—	—	—
	-84.10%	-21.30%	50.60%	806.10%	305.40%	-54.00%	8,600.00%	331.60%	—	—	—	—
	-473.80%	-909.00%	-935.00%	64.70%	-172.60%	-248.30%	253.80%	264.30%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	13.57	17.39	5.22	11.53	0.18	—
	3.62	3.49	3.46	0.75	—	—
	17.18	20.89	8.68	12.28	0.18	—
	30.70	31.39	7.72	11.74	0.18	0.20
	0.00	0.00	0.00	10.72	—	—
	9.53	11.96	4.61	—	—	—
	2.15	2.02	0.13	0.06	0.02	0.08
	4.82	4.65	0.13	0.02	0.05	0.01
	1.36	0.68	0.13	0.00	—	—
	13.27	12.44	2.78	0.94	0.12	0.11
	-13.52	-10.51	0.96	0.54	0.00	-0.20
	0.00	0.00	0.00	—	—	—
	-13.52	-10.51	0.96	0.54	0.00	-0.20
	-0.21	-0.08	0.30	0.14	0.04	0.04
	-13.31	-10.42	0.66	0.40	-0.04	-0.23
	-0.09	-0.16	0.05	0.36	-2.12	-13.52
Key metrics
	-7.34	-5.18	1.22	0.56	0.05	-0.19
	-54.09%	-29.80%	23.40%	4.90%	27.80%	—
	-98.08%	-59.90%	12.60%	3.50%	-22.20%	—
	—	-1.60%	0.30%	—	—	—
	—	233.10%	-54.70%	6,305.60%	—	—
	—	-1,678.80%	65.00%	1,100.00%	82.60%	—
	—	-2.94	-22.81	—	—	—
	—	0.28	-34.56	—	—	—
	—	0.04	0.00	—	—	—
	—	11.83	-0.29	—	—	—
	—	367.1	1,171.9	—	—	—
Balance sheet
	—	388.65	358.50	—	—	—
	—	29.58	27.55	—	—	—
	—	1.14	0.29	—	—	—
	—	20.71	17.08	—	—	—
	—	0.42	0.07	—	—	—
	—	5.18	3.01	—	—	—
	—	0.03	0.00	—	—	—
	—	3.64	0.39	—	—	—
	—	11.85	7.12	—	—	—
	—	12.97	0.00	—	—	—
	—	0.00	0.00	—	—	—
	—	12.97	0.00	—	—	—
	—	338.13	335.69	—	—	—
Cash flow
	—	-2.91	-22.81	—	—	—
	—	-13.27	-231.79	—	—	—
	—	17.02	254.88	—	—	—
	—	0.03	0.00	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +358.86%
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +5.11%
Profit YoY (TTM): -1,584.81%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +195.94%
Profit YoY (TTM): +371.52%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 63.09%

Quarter	September 2026	June 2026
Promoter %	63.09%	63.09%

Holder	Type	Holding	Previous	Change
FMV Holdings Pte Ltd	Promoter	50.78%	50.78%	0.00%
Shankar Varadharajan	Promoter	12.31%	12.31%	0.00%
VIKASA INDIA EIF I FUND	Public	2.81%	2.81%	0.00%
ROOPAL HITESH KAWA .	Public	2.47%	2.54%	-0.07%
INDIA EMERGING GIANTS FUND LIMITED	Public	2.32%	2.32%	0.00%
MAYBANK SECURITIES PTE LTD - ODI	Public	1.43%	—	—
BLUE LOTUS CAPITAL MULTI BAGGER FUND II	Public	1.26%	1.26%	0.00%
VINAY RAJENDRAKUMAR NAGDA	Public	1.16%	1.43%	-0.27%
NATWARLAL KESHAVJIBHAI KAWA	Public	1.11%	1.11%	0.00%
VRITTI HITESH KAWA .	Public	1.03%	1.03%	0.00%
HITESH NATWARLAL KAWA	Public	1.02%	1.02%	0.00%
Corporate Body- Broker	Public	0.01%	0.01%	0.00%
EIGHT MERCATUS PTE. LTD	Promoter Group	0.00%	0.00%	0.00%
KS Smart Technologies Ltd	Promoter Group	0.00%	0.00%	0.00%
Mercatus Capital Pte Ltd	Promoter Group	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Poly Medicure Ltd	16,093	1,587.65	51.43	13.20%	+18.31% TTM	-12.49% TTM	-18.70%
MOLBIO DIAGNOSTICS LIMITED	15,901	1,379.80	—	—	—	—	—
Sahajanand Medical Technologies Limited	4,939	485.85	—	—	—	—	—
FISCHER MEDICAL VENTURES LIMITED	1,655	25.29	59.29	12.70%	+195.94% TTM	+371.52% TTM	-73.00%
Tarsons Products Limited	1,651	310.35	148.83	4.80%	+10.63% TTM	-59.68% TTM	+7.85%
Laxmi Dental Limited	1,036	188.30	31.98	11.50%	+13.07% TTM	+24.85% TTM	-40.71%
Hemant Surgical Industries Limited	884	608.10	—	19.50%	—	—	+109.69%
Fabtech Technologies Limited	591	133.05	16.61	11.60%	—	—	-44.16%
Prevest Denpro Limited	480	400.00	—	21.90%	—	—	-23.80%
Nureca Limited	288	301.65	60.46	3.40%	+33.66% TTM	+15.82% TTM	+17.10%
EARKART LIMITED S	161	117.00	32.59	12.10%	—	—	-48.46%
CHOKSI ASIA LIMITED S	120	210.00	23.08	18.40%	+21.40% TTM	+132.74% TTM	+97.28%
Shree Pacetronix Ltd	63	169.15	19.60	25.00%	+22.63% TTM	+208.57% TTM	-38.65%
Amkay Products Limited S	46	53.50	20.04	13.40%	—	—	+13.88%
KMS Medisurgi Limited S	44	132.80	177.07	4.80%	—	—	—
Royal Sense Limited	36	67.70	—	26.10%	—	—	-70.69%
GKB Ophthalmics Ltd.	31	62.00	5.67	9.60%	+29.95% TTM	+170.50% TTM	-9.48%
Centenial Surgical Suture Ltd. S	26	71.96	-17.99	2.60%	+6.70% TTM	+26.29% TTM	-33.37%
Transpact Enterprises Limited S	4	100.70	—	14.50%	—	—	-57.35%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

Newspaper advertisement regarding special window for relodgement of share transfer request4 Nov 2026 · Company Update / Newspaper Publication
Appointment of Mr Chan Sing En as an Independent Director of FMV Global Innovations Pte.Ltd, Singapore, a Material Wholly Owned Subsidiary Company27 Oct 2026 · Company Update / General
Postal Ballot Notice dtd 14th October 2026 dispated to shareholders today i.e on 16th October 202616 Oct 2026 · AGM/EGM / Postal Ballot
Certificate under Reg 74(5) for the quarter ended 30th September 202614 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Postal Ballot Notice & Scrutinizer14 Oct 2026 · Others / Outcome without intimation
Scrutinizer Report and Voting Results for AGM 20261 Oct 2026 · AGM/EGM / AGM
Proceedings of the 33rd AGM of the Company29 Sep 2026 · AGM/EGM / AGM
Intimation on Material transaction by the subsidiaries28 Sep 2026 · Company Update / General
Corrigendum to the Annual Report for the FY 2025-2626 Sep 2026 · Others / Reg. 34 (1) Annual Report
Intimation of closure of Trading Window wef October 1, 202625 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
i) Rights Issue by Material Unlisted Subsidiary Companies ii) Investment in Equity shares of wholly owned Material Subsidiaries of the Company24 Sep 2026 · Others / Outcome without intimation
Revised Presentation of Investor/Analyst call17 Sep 2026 · Company Update / General
Chairman''s letter to shareholders16 Sep 2026 · Company Update / General
Newspaper Advertisement for completion of dispatch, of Annual Report FY 2025-26, to Shareholders9 Sep 2026 · Company Update / Newspaper Publication
BRSR report for the FY 2025-267 Sep 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
33rd Annual Report of Fischer Medical Ventures Limited7 Sep 2026 · Others / Reg. 34 (1) Annual Report
33rd AGM of Fischer Medical Ventures Limited is scheduled to be held on 29.09.2026 at 11:00 AM IST7 Sep 2026 · AGM/EGM / AGM
Fischer Medical Ventures Limited has informed the exchange on the presentation for the Investor/Analyst call scheduled to be held on 07.09.2026.7 Sep 2026 · Company Update / Analyst / Investor Meet
Newspaper Publication for Pre-dispatch of Notice to shareholders about AGM 20265 Sep 2026 · Company Update / Newspaper Publication
Fischer Medical Ventures Limited has informed the exchange on the Analyst/Investor Meet scheduled on 07-09-2026.4 Sep 2026 · Company Update / Analyst / Investor Meet
Intimation of Record Date for E-Voting and payment of Dividend to Shareholders3 Sep 2026 · Corp. Action / Record Date
I)Approval of Appointment of Independed Director II)Approval of AGM Notice & Book Closure III) Reconstitution of Committee3 Sep 2026 · Others / Outcome without intimation
Fischer Medical Ventures Ltd informed the exchange on the Press Release titled Time Medical International Ventures launches Next-generation CLARION 64/128- Slice AI-driven CT system at ....28 Aug 2026 · Company Update / Press Release / Media Release
Fischer Medical Ventures Limited has informed the exchange on the press release titled "Catanduanes Integrated Digital Healthcare project Awarded to Time Medical Philippines".24 Aug 2026 · Company Update / Press Release / Media Release
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shankar Varadharajan & Others18 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shankar Varadharajan & PACs18 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shankar Varadharajan & Others18 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Allotment of equity shares pursuant to conversion of warrants17 Aug 2026 · Company Update / Allotment of Equity Shares
Allotment of equity shares pursuant to conversion of warrants14 Aug 2026 · Company Update / Allotment of Equity Shares
Approval of Q 1 financial results for FY 2026-2714 Aug 2026 · Result / Financial Results
Resgination of Independent Directors14 Aug 2026 · Company Update / Resignation of Director
Approval of Q 1 financial results FY 2026-27 in alia, considered other matters.14 Aug 2026 · Board Meeting / Outcome of Board Meeting
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shankar Varadharajan & PACs14 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Monitoring Agency Report for quarter ended 30th June 202613 Aug 2026 · Company Update / Monitoring Agency Report
Allotment of equity shares pursuant to conversion of warrants13 Aug 2026 · Company Update / Allotment of Equity Shares
Allotment of Equity shares pursuant to Conversion of warrants.12 Aug 2026 · Company Update / Allotment of Equity Shares
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shankar Varadharajan & PACs12 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Allotment of 23,00,000 Equity shares pursuant to conversion of warrants11 Aug 2026 · Company Update / Allotment of Equity Shares
Newspaper Advt- Special Window for Re-lodgement of Transfer Request for Physical Shares11 Aug 2026 · Company Update / Newspaper Publication
Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve un-audited financial ....7 Aug 2026 · Board Meeting / Board Meeting

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 0.0500	22 Sep 2026	22 Sep 2026	—
Final Dividend - Rs. - 0.0050	22 Sep 2025	22 Sep 2025	—
Stock Split From Rs.10/- to Rs.1/-	12 Sep 2025	12 Sep 2025	—

Board meetings

14 Aug 2026 Board Meeting - Financial Results